2022 Acta_Neurologica_Belgica - Marx - New onset refractory status epilepticus and neuroendocrine tumour- a case report and review of the literature.pdf
Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC et al (2015) New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 85(18):1604–1613. 10.1212/WNL.0000000000001940 DOI: 10.1212/WNL.0000000000001940
Graus F, Titulaer MJ, Balu R, Benseler SM, Bien CG, Cellucci T et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol NIH 15(4):391–404 DOI: 10.1016/S1474-4422(15)00401-9
Kaltsas G, Androulakis II, De Herder WW, Grossman AB (2010) Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer 17(3):173–193 DOI: 10.1677/ERC-10-0024
André A, Félix A, Shamasna M, Nzwalo H, Basílio C (2017) Neuroendocrine tumour metastatic brain disease during immunosuppressive treatment for paraneoplastic GABAB receptor antibodies encephalitis: Is immunosuppression always beneficial? J Neuroimmunol 310:66–68. 10.1016/j.jneuroim.2017.06.009 DOI: 10.1016/j.jneuroim.2017.06.009
